drugset / Trial / NCT00006380
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Treatment
Summary
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have prostate cancer that no longer responds to antiandrogen therapy.
Timeline
- Start
- 2000-09
- Primary completion
- 2002-03
- Completion
- 2002-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | muJ591 | Monoclonal antibody | — | Intravenous |